100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Abstract

In this review, we bring our personal experiences to showcase insulin from its breakthrough discovery as a life-saving drug 100 years ago to its uncovering as the autoantigen and potential cause of type 1 diabetes and eventually as an opportunity to prevent autoimmune diabetes. The work covers the birth of insulin to treat patients, which is now 100 years ago, the development of human insulin, insulin analogues, devices, and the way into automated insulin delivery, the realization that insulin is the primary autoimmune target of type 1 diabetes in children, novel approaches of immunotherapy using insulin for immune tolerance induction, the possible limitations of insulin immunotherapy, and an outlook how modern vaccines could remove the need for another 100 years of insulin therapy.

• Authors: Anette-Gabriele Ziegler, Thomas Danne, Carolin Daniel, Ezio Bonifacio
• Journal: Med (New York, N.Y.) (Med) Vol. 2 Issue 10 Pg. 1120-1137 (10 08 2021) ISSN: 2666-6340 [Electronic] United States
• PMID: 34993499 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Autoantigens
• Insulin
• Insulin, Regular, Human

Topics

• Autoantigens
• Autoimmunity
• Child
• Diabetes Mellitus, Type 1 (drug therapy)
• Humans
• Immune Tolerance
• Insulin (therapeutic use)
• Insulin, Regular, Human (therapeutic use)